These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 66320)

  • 1. Separation of the complement-fixing and early antigens from Epstein-Barr soluble antigen.
    Wainwright WH; Veltri RW
    J Natl Cancer Inst; 1977 Apr; 58(4):1111-3. PubMed ID: 66320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic identification of Epstein-Barr virus early antigen in a P3HR-1 cell extract.
    Veltri RW; Wainwright WH; Sprinkle PM
    J Natl Cancer Inst; 1976 Aug; 57(2):245-53. PubMed ID: 187767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble complement fixing antigens in Epstein-Barr virus cell systems.
    Twardzik DR; Ablashi DV; Easton JM; Armstrong GR
    Bibl Haematol; 1975 Oct; (43):412-6. PubMed ID: 183710
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification of soluble complement-fixing antigens from two Burkitt's lymphoma cell lines. Conditions affecting the stability and recovery of antigens and antibodies.
    Weliky N; Leaman DH; Kallman BJ
    Immunology; 1975 Oct; 29(4):779-90. PubMed ID: 241721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Epstein-Barr virus (EBV) antigens II. Detection of early antigen (S) using anticomplement immunofluorescence (ACIF) et complement fixation (CF) tests.
    Lenoir G; Berthelon MC; Favre MC; De-Thé G
    Biomedicine; 1975 Dec; 23(10):461-4. PubMed ID: 177116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunoelectron microscopic analysis of Epstein-Barr virus-associated complement-fixing antigen.
    Shamoto M; Suzuki I
    Cancer; 1976 Nov; 38(5):2057-64. PubMed ID: 186178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Epstein-Barr virus antigens. I. Biochemical analysis of the complement-fixing soluble antigen and relationship with Epstein-Barr virus-associated nuclear antigen.
    Lenoir G; Berthelon MC; Favre MC; de-Thé G
    J Virol; 1976 Feb; 17(2):672-4. PubMed ID: 176436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New method for detecting Epstein-Barr virus association in nonproducer lymphoblastoid cell lines.
    Giunta S; Groppa G
    Cancer Res; 1983 Nov; 43(11):5064-7. PubMed ID: 6311404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct antigenic components in an Epstein-Barr virus-related early product induced by halogenated pyrimidines in non-producing human lymphoblastoid cells.
    Sugawara K; Osato T
    Nat New Biol; 1973 Jun; 243(128):209-10. PubMed ID: 4351756
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential expression of D and R components of Epstein-Barr virus early antigen after superinfection and after induction with 5-iododeoxyuridine.
    Simonová I; Závadová H; Vonka V
    Acta Virol; 1977 May; 21(3):184-8. PubMed ID: 18915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells.
    Prachová K; Roubal J
    Acta Virol; 1981 May; 25(3):163-6. PubMed ID: 6115566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of soluble antigen of Epstein-Barr virus by the enzyme-linked immunosorbent assay.
    Wallen WC; Mattson JM; Levine PH
    J Infect Dis; 1977 Oct; 136 Suppl():S324-8. PubMed ID: 198494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
    Boguszaková L; Hirsch I; Brichácek B; Vonka V
    J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential induction of Epstein-Barr virus-related antigens in heterokaryon cultures.
    Yamamoto K; Osato T
    Int J Cancer; 1977 Jun; 19(6):767-74. PubMed ID: 194844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes.
    Ohno S; Luka J; Lindahl T; Klein G
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1605-9. PubMed ID: 67603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inducibility of Epstein-Barr virus in cloned, non-producer Raji cells.
    Bister K; Yamamoto N; zur Hausen H
    Int J Cancer; 1979 Jun; 23(6):818-25. PubMed ID: 89100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective stimulation and differentiation of early antigens in lymphoblastoid cell lines producing Epstein-Barr-like viruses.
    Neubauer RH; Rabin H; Brown AM
    J Gen Virol; 1978 Nov; 41(2):295-301. PubMed ID: 82609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
    Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
    Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.